Multifunctional indanone–chalcone hybrid compounds with anti-β-amyloid (Aβ) aggregation, monoamine oxidase B (MAO-B) inhibition and neuroprotective properties against Alzheimer’s disease

[1]  Hua Zhang,et al.  Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation , 2019, Molecules.

[2]  Wenmin Liu,et al.  Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease. , 2018, ACS chemical neuroscience.

[3]  S. Sensi,et al.  Copper and Zinc Dysregulation in Alzheimer's Disease. , 2018, Trends in pharmacological sciences.

[4]  Kris Simone Tranches Dias,et al.  Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update. , 2018, Current medicinal chemistry.

[5]  D. Lamba,et al.  Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues. , 2018 .

[6]  Nasimul Hoda,et al.  Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules. , 2018, Current topics in medicinal chemistry.

[7]  D. Lamba,et al.  Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues , 2018, Journal of enzyme inhibition and medicinal chemistry.

[8]  J. Hardy,et al.  Alzheimer's disease , 2018, European journal of neurology.

[9]  S. Patil,et al.  Recent developments in biological activities of indanones. , 2017, European journal of medicinal chemistry.

[10]  J. Andersen,et al.  Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[11]  Ernesto Fedele,et al.  The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind , 2017, Current neuropharmacology.

[12]  C. Xing,et al.  Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.

[13]  Yan Li,et al.  Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. , 2017, Bioorganic & medicinal chemistry.

[14]  B. Kumar,et al.  A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities. , 2016, Current drug targets.

[15]  Yan Li,et al.  Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer's disease. , 2016, Bioorganic & medicinal chemistry.

[16]  D. Desiderio,et al.  Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors. , 2016, ACS medicinal chemistry letters.

[17]  T. H. Ferreira-Vieira,et al.  Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.

[18]  Youfu Luo,et al.  Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. , 2015, European journal of medicinal chemistry.

[19]  S. Vilar,et al.  Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. , 2013, European journal of medicinal chemistry.

[20]  Xingshu Li,et al.  Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease. , 2012, Journal of medicinal chemistry.

[21]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[22]  Li Di,et al.  High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.